Lobbying Update: $30,000 of LEONARDO DRS INC (FORMER DRS TECHNOLOGIES INC.) lobbying was just disclosed

$30,000 of LEONARDO DRS INC (FORMER DRS TECHNOLOGIES INC.) lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"DOD RDT&E Issues"

You can find more data on corporate lobbying on Quiver Quantitative.

DRS Insider Trading Activity

DRS insiders have traded $DRS stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $DRS stock by insiders over the last 6 months:

• JOHN BAYLOUNY (EVP and COO) has traded it 2 times. They made 0 purchases and 2 sales, selling 11,764 shares.
• MARK DORFMAN (EVP, GC and Secretary) sold 23,042 shares.
• PAMELA MORROW (SVP and Controller) sold 11,100 shares.
• SALLY WALLACE (EVP, Business Operations) sold 4,339 shares.
• WILLIAM III LYNN (Chief Executive Officer) sold 45,000 shares.
• MICHAEL DIPPOLD (EVP and CFO) sold 25,880 shares.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

DRS Hedge Fund Activity

We have seen 116 institutional investors add shares of DRS stock to their portfolio, and 67 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• SILVERCREST ASSET MANAGEMENT GROUP LLC removed 3,957,551 shares (-63.4%) from their portfolio in Q3 2024
• BROWN ADVISORY INC removed 816,354 shares (-55.6%) from their portfolio in Q3 2024
• FMR LLC removed 779,197 shares (-39.0%) from their portfolio in Q3 2024
• FIRST TRUST ADVISORS LP added 766,282 shares (+139.5%) to their portfolio in Q3 2024
• GOLDMAN SACHS GROUP INC added 703,989 shares (+382.5%) to their portfolio in Q3 2024
• LOOMIS SAYLES & CO L P removed 703,230 shares (-95.1%) from their portfolio in Q3 2024
• ALLIANCEBERNSTEIN L.P. removed 622,487 shares (-14.8%) from their portfolio in Q3 2024

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.